Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Sofosbuvir And Velpatasvir, Atc J05ap55 For The Period 01.05.2630.04.28 2026-09-14
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Finished Medicinal Products Mentioned In The R 2026-09-14
Germany Clostridium Botulinum (incobotulinum) Toxin Type A_tk, Hek, Hkk 2026-09-14
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-09-14
Germany Clostridium Botulinum (onabotulinum) Toxin Type A_tk, Hek, Hkk 2026-09-14
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-09-14
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Trientine (exclusively Dosage Form Fta), Atc A16ax12 For The Period 05/01/26-04/30/28 2026-09-14
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Trientine (exclusively Dosage Form Hkp), Atc A16ax12 For The Period 01.05.26-30.04.28 2026-09-14
Whats app